Kenya Is Among African Countries That Take Pride In The Success Of Their Fight Against Tb Among Other Serious Ailments. However, The Entry Of COVID 19 According To The Ministry Of Health Is Threatening To Reverse These Gains Through Low Turnout For Screening Or Treatment Raising The Risk For Development Of Multi Drug Resistant Tb That Costs Up To Two Million Shillings To Treat.